Novaccess Global Inc XSNX

Healthcare Biotechnology

NovAccess Global Inc. is a biopharmaceutical company, which develops immunotherapies to treat brain tumor patients in the United States. The Company specializes in research related to utilizing a patient’s own immune system to attack the cancer. Its dendritic cell-based immunotherapy utilizes a combination of Toll-like receptor adjuvants for an enhanced antitumor response. The therapy is designed to utilize the patient’s tumor antigens and immune cells, dendritic cells, in combination with TLR adjuvants to initiate an efficient antitumor immune response. This process includes obtaining the patients' tumor cells after surgery, and precursors cells that are matured into dendritic cells from peripheral blood. Its TLR-AD1 platform technology is a vaccine immunotherapy for the treatment of aggressive brain cancers, including glioblastoma and other high-grade gliomas. TLR-AD1 technology has a scope of use and is embodied in various different product lines for different clinical situations.

OTCPK:XSNX - Post by User

Novaccess Global Inc > reposted link...you can see the need of solar power cannibas

<< Previous

Bullboard Posts

Next >>

Comment by Peanutbudderon Jan 11, 2018 3:43pm

68 Views

Post# 27336117

RE:RE:RE:reposted link...you can see the need of solar power cannibas

games in my oponion. Been watching this guy knock the SP down and down. Moved his wall from 0 0022 to 0.002 down to 0.0018 to 0.0015 and now to the point were we have it. He also takes his sell orders on and off so his shares stay at the back of the que.. he was buying (275,000) on the bid at 0.001. Plus I imagine lots of people trapped about 0.002 are getting shaken out and selling for a loss

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale